IGKC	gene symbol: IGKC. Functionality: encodes immunoglobulin kappa light chain; involved in antigen recognition and immune response. Phenotype: associated with immune system functioning; potential marker in her2-positive breast cancer prognosis. 
TMSB10	gene symbol: TMSB10. Functionality: regulates actin cytoskeleton dynamics, cell migration, proliferation. Phenotype: involved in tumor progression, metastasis in her2-positive breast cancer. 
ERBB2	gene symbol: ERBB2. Functionality: encodes transmembrane receptor tyrosine kinase, part of egfr family, involved in cell growth and differentiation signaling. Phenotype: overexpression leads to aggressive her2-positive breast cancer, characterized by rapid tumor growth and poor prognosis. 
IGHG3	gene symbol: IGHG3. Functionality: encodes gamma-3 heavy chain of immunoglobulin g; involved in immune response and antibody-mediated mechanisms. Phenotype: influences antibody structure and function; may impact susceptibility to infections and autoimmune conditions; potential association with specific cancer subtypes. 
IGLC2	gene symbol: IGLC2. Functionality: codes for lambda light chain of immunoglobulin; involved in immune response. Phenotype: may affect antibody structure; potential implications in immune-related pathologies. 
IGHA1	gene symbol: IGHA1. Functionality: encodes alpha heavy chain of iga antibodies, mediates immune response. Phenotype: associated with immune system function, impacts mucosal immunity. 
GAPDH	gene symbol: GAPDH. Functionality: catalyzes glycolysis; involved in energy production and apoptosis regulation. Phenotype: altered expression linked to cancer progression and metabolic dysregulation. 
ACTB	gene symbol: ACTB. Functionality: cytoskeletal structural protein, actin filament formation, cell motility. Phenotype: increased cell proliferation, abnormal cell morphology, potential tumorigenesis. 
IGLC3	gene symbol: IGLC3. Functionality: encodes immunoglobulin lambda constant 3 chain, involved in immune response. Phenotype: altered expression may affect antibody diversity; role in her2-positive breast cancer unclear. 
IGHM	gene symbol: IGHM. Functionality: encodes immunoglobulin heavy constant mu chain; involved in primary immune response. Phenotype: associated with immune system disorders; potential impact on tumor progression in her2-positive breast cancer. 
SERF2	gene symbol: SERF2. Functionality: involved in protein folding and aggregation; interacts with amyloid precursor proteins. Phenotype: altered protein aggregation linked to neurodegenerative diseases; potential role in cancer progression. 
PSMB3	gene symbol: PSMB3. Functionality: encodes proteasome subunit beta type-3; involved in protein degradation. Phenotype: altered expression linked to tumorigenesis; impacts cell cycle regulation in her2-positive breast cancer. 
PFN1	gene symbol: PFN1. Functionality: actin-binding protein; regulates actin polymerization; involved in cell motility and signal transduction pathways. Phenotype: altered cell migration; associated with cancer progression and metastasis; potential role in her2-positive breast cancer. 
ACTG1	gene symbol: ACTG1. Functionality: involved in cell motility, cytoskeletal structure, and intracellular transport. Phenotype: altered expression linked to cancer progression, including her2-positive breast cancer. 
KRT19	gene symbol: KRT19. Functionality: encodes keratin protein involved in cellular structural integrity and epithelial cell differentiation. Phenotype: associated with her2-positive breast cancer; used as a tumor marker for detection and prognosis. 
RACK1	gene symbol: RACK1. Functionality: scaffold protein, signal transduction, cell growth, protein kinase c regulation. Phenotype: tumor progression, metastasis, her2-positive breast cancer. 
MUCL1	gene symbol: MUCL1. Functionality: expressed in mammary tissue, may play role in mucin-type glycoprotein synthesis, involvement in cellular adhesion. Phenotype: elevated expression in her2-positive breast cancer, potential biomarker for breast cancer diagnosis, association with tumor progression. 
CISD3	gene symbol: CISD3. Functionality: encodes a protein involved in iron-sulfur cluster binding and mitochondrial function. Phenotype: linked to cellular proliferation and survival in her2-positive breast cancer. 
APOE	gene symbol: APOE. Functionality: lipid metabolism regulation, cholesterol transport, brain function. Phenotype: increased risk of alzheimer's, cardiovascular diseases, neurodegeneration. 
MIEN1	gene symbol: MIEN1. Functionality: promotes cancer cell migration and invasion, modulates signaling pathways. Phenotype: her2-positive breast cancer progression, associated with aggressive tumor behavior. 
SSR4	gene symbol: SSR4. Functionality: integral component of signal sequence receptor complex; involved in protein targeting to endoplasmic reticulum membrane; participates in glycosylation. Phenotype: associated with altered protein processing; may influence susceptibility to her2-positive breast cancer; potential link to dysregulated cellular signaling. 
CALR	gene symbol: CALR. Functionality: calcium-binding chaperone, involved in protein folding, glycoprotein quality control, calcium homeostasis. Phenotype: altered calcium signaling, increased cell proliferation, potential contribution to oncogenesis, immune modulation. 
PSAP	gene symbol: PSAP. Functionality: encodes prosaposin, a precursor for saposins involved in lysosomal lipid metabolism. Phenotype: altered expression associated with lipid storage disorders; impacts cell growth and survival in her2-positive breast cancer. 
CTSD	gene symbol: CTSD. Functionality: encodes cathepsin d, lysosomal protease, involved in protein degradation, apoptosis, and hormone processing. Phenotype: overexpression in her2-positive breast cancer associated with tumor progression and metastasis. 
FTL	gene symbol: FTL. Functionality: encodes ferritin light chain; regulates iron storage and homeostasis; involved in cellular iron metabolism. Phenotype: altered iron levels; associated with neurodegeneration and cataract formation; potential involvement in cancer progression. 
FTH1	gene symbol: FTH1. Functionality: iron storage, cellular iron homeostasis, oxidative stress response. Phenotype: iron overload, altered oxidative stress response, potential modulation in cancer progression. 
TPT1	gene symbol: TPT1. Functionality: regulates cell growth and apoptosis; involved in calcium binding and microtubule stabilization. Phenotype: associated with cell proliferation; implicated in cancer progression, including her2-positive breast cancer. 
PTPRF	gene symbol: PTPRF. Functionality: protein tyrosine phosphatase involved in dephosphorylation, cell signaling regulation, and cellular adhesion processes. Phenotype: altered ptprf expression linked to her2-positive breast cancer progression and metastasis, influencing tumor growth and cell adhesion. 
UBA52	gene symbol: UBA52. Functionality: encodes ubiquitin fused to ribosomal protein l40, involved in protein degradation and ribosome biogenesis. Phenotype: altered expression linked to tumorigenesis, including her2-positive breast cancer, impacting cell growth and survival. 
P4HB	gene symbol: P4HB. Functionality: catalyzes disulfide bond formation, isomerization, and reduction in proteins; important in cellular redox homeostasis. Phenotype: altered expression can affect cancer cell proliferation, survival, and metastasis; linked with drug resistance in her2-positive breast cancer. 
BEST1	gene symbol: BEST1. Functionality: encodes a calcium-activated chloride channel involved in retinal ion transport. Phenotype: associated with retinal dystrophies; no direct link to her2-positive breast cancer. 
HLA-B	gene symbol: HLA-B. Functionality: major histocompatibility complex class i molecule; presents peptides to immune system; involved in immune response regulation. Phenotype: influences antigen presentation; impacts immune recognition and response; associated with autoimmune diseases and cancer susceptibility. 
FAU	gene symbol: FAU. Functionality: protein synthesis, ribosomal biogenesis, ubiquitin-like fusion protein formation. Phenotype: cell growth regulation, apoptosis modulation, oncogenic transformation potential. 
SLC9A3R1	gene symbol: SLC9A3R1. Functionality: regulates ion transport, interacts with signaling pathways, modulates cellular proliferation. Phenotype: altered expression linked to cancer progression, affects cell growth in her2-positive breast cancer. 
FN1	gene symbol: FN1. Functionality: extracellular matrix organization, cell adhesion, migration, wound healing, signal transduction. Phenotype: altered cell adhesion, increased metastasis potential, enhanced tumorigenicity. 
COL1A1	gene symbol: COL1A1. Functionality: encodes type i collagen alpha 1 chain; structural component of extracellular matrix. Phenotype: mutations can lead to osteogenesis imperfecta; associated with bone fragility and connective tissue disorders. 
EEF2	gene symbol: EEF2. Functionality: encodes eukaryotic elongation factor 2, involved in protein synthesis and translation elongation. Phenotype: potential overexpression in cancer cells, contributing to rapid cell growth; associated with her2-positive breast cancer progression. 
IGHG4	gene symbol: IGHG4. Functionality: encodes gamma 4 heavy chain of immunoglobulin g, involved in immune response. Phenotype: may influence immune system activity; not directly linked to her2-positive breast cancer. 
CALML5	gene symbol: CALML5. Functionality: calcium-binding protein involved in epidermal differentiation, cell proliferation, and apoptosis. Phenotype: associated with skin barrier function; potential role in cancer cell growth and her2-positive breast cancer. 
CD74	gene symbol: CD74. Functionality: regulates immune response, acts as mhc class ii chaperone, involved in antigen presentation. Phenotype: altered immune response, associated with tumor progression and metastasis in her2-positive breast cancer. 
B2M	gene symbol: B2M. Functionality: component of mhc class i molecules, involved in antigen presentation and immune response regulation. Phenotype: altered expression may impact immune system function; associated with tumor progression and metastasis in her2-positive breast cancer. 
FASN	gene symbol: FASN. Functionality: catalyzes fatty acid synthesis, involved in lipogenesis and energy metabolism. Phenotype: increased expression linked to tumor growth, aggressiveness, and poor prognosis in her2-positive breast cancer. 
S100A9	gene symbol: S100A9. Functionality: calcium-binding protein, modulates inflammatory processes, regulates immune response. Phenotype: associated with metastasis, immune evasion, contributes to tumor microenvironment in her2-positive breast cancer. 
MGP	gene symbol: MGP. Functionality: encodes matrix gla protein, regulates extracellular matrix mineralization, inhibits vascular calcification. Phenotype: altered expression linked to her2-positive breast cancer progression and metastasis. 
CFL1	gene symbol: CFL1. Functionality: regulates actin filament dynamics, involved in cytoskeleton organization and cell motility. Phenotype: altered expression may contribute to cancer cell invasion and metastasis, observed in her2-positive breast cancer. 
PSMD3	gene symbol: PSMD3. Functionality: proteasome subunit, ubiquitin-dependent protein degradation, regulation of cellular processes. Phenotype: her2-positive breast cancer, cell proliferation, tumor progression. 
IGHG1	gene symbol: IGHG1. Functionality: codes for immunoglobulin heavy constant gamma 1; involved in immune response. Phenotype: impacts immune system; associated with antibody-dependent cellular cytotoxicity. 
HLA-A	gene symbol: HLA-A. Functionality: encodes mhc class i molecule, presents endogenous peptides to t cells. Phenotype: influences immune response, antigen presentation in her2-positive breast cancer. 
S100A6	gene symbol: S100A6. Functionality: calcium-binding protein; involved in cell cycle regulation, cell growth, and differentiation. Phenotype: may contribute to tumor growth and metastasis in her2-positive breast cancer. 
MYL6	gene symbol: MYL6. Functionality: myl6 encodes myosin light chain 6, involved in muscle contraction and cellular movement. Phenotype: alterations may affect muscle function; association with her2-positive breast cancer not well-established. 
COL1A2	gene symbol: COL1A2. Functionality: encodes type i collagen alpha-2 chain; involved in extracellular matrix formation; contributes to tissue strength and integrity. Phenotype: associated with connective tissue disorders; may influence tumor microenvironment in her2-positive breast cancer. 
PHB	gene symbol: PHB. Functionality: gene involved in cell cycle regulation, mitochondrial function, and cellular senescence. Phenotype: overexpression linked to her2-positive breast cancer, affecting tumor proliferation and survival. 
TAGLN2	gene symbol: TAGLN2. Functionality: actin-binding protein involved in cytoskeletal organization and cell motility. Phenotype: promotes invasion and metastasis in her2-positive breast cancer. 
HLA-E	gene symbol: HLA-E. Functionality: encodes for mhc class i molecule, involved in immune response regulation, presents peptide fragments to immune cells. Phenotype: altered expression linked to immune evasion in cancer, potential role in tumor progression, increased tolerance in her2-positive breast cancer. 
HLA-C	gene symbol: HLA-C. Functionality: part of major histocompatibility complex, presents peptides to immune cells, influences immune response. Phenotype: affects susceptibility to infections, autoimmune diseases, and cancer progression. 
KRT7	gene symbol: KRT7. Functionality: encodes keratin 7 protein; involved in cellular structure and integrity; participates in epithelial cell differentiation. Phenotype: associated with her2-positive breast cancer; linked to tumor cell proliferation and progression; impacts epithelial tumor behavior. 
CD63	gene symbol: CD63. Functionality: involved in cell adhesion, protein trafficking, immune response. Phenotype: expressed in various tissues, influences tumor progression, metastasis. 
SYNGR2	gene symbol: SYNGR2. Functionality: synaptic vesicle membrane protein involved in neurotransmitter release and synaptic transmission. Phenotype: potential role in neuronal signaling; possible association with cognitive function and neurological disorders. 
STARD3	gene symbol: STARD3. Functionality: lipid transport, cholesterol homeostasis, intracellular signaling. Phenotype: her2-positive breast cancer, tumor growth, progression. 
PABPC1	gene symbol: PABPC1. Functionality: regulates mrna stability and translation; interacts with poly(a) tail. Phenotype: altered expression linked to cell growth and proliferation; potential role in her2-positive breast cancer progression. 
GPX4	gene symbol: GPX4. Functionality: encodes enzyme glutathione peroxidase; reduces lipid hydroperoxides; protects cells from oxidative damage. Phenotype: lipid metabolism regulation; cellular protection; potential involvement in tumorigenesis; impact on cancer cell proliferation. 
GRB7	gene symbol: GRB7. Functionality: adaptor protein; links receptor tyrosine kinases to downstream signaling pathways; involved in cell migration, growth, and proliferation. Phenotype: overexpression associated with her2-positive breast cancer; contributes to tumor progression and poor prognosis. 
SLC25A6	gene symbol: SLC25A6. Functionality: encodes a mitochondrial adenine nucleotide translocator; involved in adp/atp exchange. Phenotype: altered expression may impact cellular energy metabolism; potential role in cancer cell proliferation. 
AEBP1	gene symbol: AEBP1. Functionality: transcriptional repressor, involved in adipogenesis and inflammatory response regulation. Phenotype: altered expression linked to tumor progression, metastasis, and cancer cell proliferation. 
GNAS	gene symbol: GNAS. Functionality: encodes g-protein alpha subunit, mediates hormone signaling. Phenotype: involvement in endocrine tumors, potential role in breast cancer progression. 
NDUFB9	gene symbol: NDUFB9. Functionality: encodes a subunit of mitochondrial complex i involved in oxidative phosphorylation. Phenotype: may influence cellular energy metabolism and contribute to her2-positive breast cancer aggressiveness. 
EDF1	gene symbol: EDF1. Functionality: regulates transcription; modulates rna polymerase ii; interacts with nuclear receptors. Phenotype: altered cell proliferation; potential role in tumorigenesis; associated with her2 signaling pathways. 
CRIP2	gene symbol: CRIP2. Functionality: transcription regulation, cytoskeletal organization, cell signaling. Phenotype: altered cell proliferation, differentiation, associated with her2-positive breast cancer. 
DDX5	gene symbol: DDX5. Functionality: rna helicase, transcription regulation, rna splicing, translation initiation. Phenotype: her2-positive breast cancer, cell proliferation, tumor progression, metastasis. 
OAZ1	gene symbol: OAZ1. Functionality: regulates polyamine biosynthesis, inhibits ornithine decarboxylase, modulates cell growth. Phenotype: altered expression may affect cancer progression, potential involvement in her2-positive breast cancer. 
EIF4G1	gene symbol: EIF4G1. Functionality: scaffold protein for translation initiation complex assembly, mediates mrna recruitment to ribosome. Phenotype: may influence cell proliferation and survival; associated with cancer progression, including her2-positive breast cancer. 
LMNA	gene symbol: LMNA. Functionality: encodes nuclear lamins a and c, structural proteins involved in nuclear envelope integrity and chromatin organization. Phenotype: mutations linked to laminopathies; her2-positive breast cancer association unclear but may affect cell division and stability. 
GNB2	gene symbol: GNB2. Functionality: encodes beta subunit of heterotrimeric g proteins involved in signal transduction. Phenotype: associated with cell proliferation, survival, and metastasis in her2-positive breast cancer. 
CST3	gene symbol: CST3. Functionality: encodes cystatin c, inhibits cysteine proteases, regulates cathepsin activity. Phenotype: elevated levels in her2-positive breast cancer, affects tumor growth and metastasis. 
PCGF2	gene symbol: PCGF2. Functionality: polycomb group protein involved in transcriptional repression, chromatin remodeling, and epigenetic regulation. Phenotype: altered expression can influence cell proliferation, differentiation, and oncogenesis, potentially impacting her2-positive breast cancer progression. 
SDC1	gene symbol: SDC1. Functionality: cell adhesion, regulation of signaling pathways, modulation of cell growth and differentiation. Phenotype: altered cell-cell communication, increased tumor growth and progression, association with poor prognosis in her2-positive breast cancer. 
S100A11	gene symbol: S100A11. Functionality: calcium-binding protein, involved in cell cycle regulation, apoptosis, and differentiation. Phenotype: altered expression in her2-positive breast cancer, affecting tumor progression and metastasis. 
PRDX1	gene symbol: PRDX1. Functionality: antioxidant enzyme, reduces hydrogen peroxide, regulates oxidative stress, cell proliferation, apoptosis. Phenotype: increased oxidative stress sensitivity, altered cell cycle, tumor progression, resistance to apoptosis. 
GRINA	gene symbol: GRINA. Functionality: involved in glutamate receptor activity modulation and apoptosis regulation. Phenotype: altered glutamate signaling; potential role in tumor cell survival and progression. 
ATP6V0B	gene symbol: ATP6V0B. Functionality: encodes a subunit of vacuolar atpase involved in acidification of intracellular compartments. Phenotype: alters cellular ph balance, potentially affecting cancer cell survival and proliferation in her2-positive breast cancer. 
TFF3	gene symbol: TFF3. Functionality: involved in mucosal protection and repair, regulation of epithelial cell interactions. Phenotype: associated with cell proliferation, migration; implicated in her2-positive breast cancer progression. 
HLA-DRA	gene symbol: HLA-DRA. Functionality: major histocompatibility complex class ii, involved in antigen presentation to t cells. Phenotype: altered immune response, potential implications in cancer growth and progression. 
EEF1D	gene symbol: EEF1D. Functionality: protein synthesis, elongation factor, translation regulation. Phenotype: cell proliferation, her2-positive breast cancer progression, tumor growth. 
AZGP1	gene symbol: AZGP1. Functionality: encodes a secreted glycoprotein involved in lipid mobilization and modulation of immune response. Phenotype: associated with tumor progression and metastasis; linked to her2-positive breast cancer prognosis. 
PPP1CA	gene symbol: PPP1CA. Functionality: protein phosphatase involved in cell cycle regulation, apoptosis, and signal transduction. Phenotype: altered expression linked to tumor growth, resistance to therapy, and progression in her2-positive breast cancer. 
FLNA	gene symbol: FLNA. Functionality: encodes filamin a protein involved in cytoskeleton organization, cell migration, and signaling pathways. Phenotype: altered expression linked to cancer progression, metastasis, and drug resistance in her2-positive breast cancer. 
COL3A1	gene symbol: COL3A1. Functionality: encodes type iii collagen, involved in extracellular matrix structure, tissue repair, and cell adhesion. Phenotype: altered expression may affect skin elasticity, wound healing, and fibrosis; implications in connective tissue disorders. 
ATP5E	gene symbol: ATP5E. Functionality: encodes a subunit of atp synthase, involved in mitochondrial atp production. Phenotype: alteration can affect cellular energy metabolism, potentially impacting cancer cell growth. 
SPDEF	gene symbol: SPDEF. Functionality: transcription factor regulating prostate and breast epithelial cell differentiation, influencing gene expression linked to tumorigenesis. Phenotype: altered expression in her2-positive breast cancer, contributing to tumor progression and metastasis. 
AP000769.1	gene symbol: AP000769.1. Functionality: associated with gene expression regulation in breast cancer.Phenotype: correlated with increased her2-positive breast cancer severity.
ALDOA	gene symbol: ALDOA. Functionality: glycolysis enzyme, catalyzes fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. Phenotype: overexpression linked to cancer cell proliferation, altered metabolism, contributes to tumorigenesis. 
PLXNB2	gene symbol: PLXNB2. Functionality: encodes receptor for semaphorin, involved in cell signaling, axon guidance. Phenotype: altered expression may affect tumor growth, possibly linked to cancer progression. 
TAGLN	gene symbol: TAGLN. Functionality: actin-binding protein involved in cytoskeleton organization and cell motility. Phenotype: altered expression linked to cancer progression, including her2-positive breast cancer. 
TUBA1B	gene symbol: TUBA1B. Functionality: essential for microtubule formation, facilitates intracellular transport and cell division, interacts with various proteins. Phenotype: altered expression may contribute to cancer progression, linked to cell proliferation, migration, and her2-positive breast cancer aggressiveness. 
APOC1	gene symbol: APOC1. Functionality: regulates lipid metabolism, inhibits lipoprotein lipase, influences cholesterol transport. Phenotype: associated with altered lipid profiles, cardiovascular risk, metabolic disorders. 
PRRC2A	gene symbol: PRRC2A. Functionality: rna-binding; regulation of mrna stability; involved in cell cycle control. Phenotype: associated with tumorigenesis; may influence cancer progression and response to therapies. 
LAPTM5	gene symbol: LAPTM5. Functionality: involved in lysosomal trafficking and degradation of membrane proteins. Phenotype: altered expression linked to immune system regulation and potential impact on her2-positive breast cancer progression. 
PTMS	gene symbol: PTMS. Functionality: involved in cellular processes, potentially regulatory roles in gene expression. Phenotype: altered expression may contribute to tumorigenesis; linked to proliferation in her2-positive breast cancer. 
KRT18	gene symbol: KRT18. Functionality: intermediate filament protein, structural support in epithelial cells, involved in apoptosis. Phenotype: expression in epithelial tissues, altered in cancer, associated with her2-positive breast cancer progression. 
IFI27	gene symbol: IFI27. Functionality: encodes interferon-alpha-inducible protein; involved in apoptosis and immune response. Phenotype: overexpression associated with cell proliferation; relevant in her2-positive breast cancer progression. 
PLD3	gene symbol: PLD3. Functionality: phospholipase d3 involved in lipid metabolism; potential role in signal transduction pathways. Phenotype: altered expression linked to breast cancer progression; may influence cell proliferation and metastasis. 
ADAM15	gene symbol: ADAM15. Functionality: metalloprotease activity, cell adhesion, signal transduction. Phenotype: altered cell proliferation, invasion, metastasis; her2-positive breast cancer association. 
C1QA	gene symbol: C1QA. Functionality: encodes complement component 1q subcomponent a chain, part of complement system for immunity. Phenotype: may influence immune response; potential link to inflammation and cancer progression. 
AES	gene symbol: AES. Functionality: acts as a transcriptional corepressor and may interact with notch signaling pathways. Phenotype: potential involvement in tumor suppression; may influence cellular proliferation and differentiation in her2-positive breast cancer. 
TSPO	gene symbol: TSPO. Functionality: involved in cholesterol transport, steroid synthesis, and apoptosis. Phenotype: affects cellular proliferation and survival in her2-positive breast cancer. 
MLLT6	gene symbol: MLLT6. Functionality: involved in transcription regulation and chromatin remodeling; may interact with oncogenic pathways. Phenotype: altered gene expression; potential role in tumorigenesis and cancer progression. 
TAPBP	gene symbol: TAPBP. Functionality: tapbp encodes tapasin, involved in antigen presentation; stabilizes mhc class i molecules. Phenotype: alteration may affect immune response; linked to cancer progression and immune evasion. 
SCAND1	gene symbol: SCAND1. Functionality: transcription regulation, chromatin remodeling. Phenotype: enhanced cell proliferation, tumorigenesis. 
ATP1A1	gene symbol: ATP1A1. Functionality: encodes catalytic subunit of na+/k+ atpase, crucial for maintaining electrochemical gradients across the plasma membrane. Phenotype: altered expression linked to her2-positive breast cancer, affecting cell proliferation and survival. 
CD81	gene symbol: CD81. Functionality: involved in cell adhesion, immune response, and signal transduction. Phenotype: alters immune cell function, influences cancer progression, and metastasis. 
SEC61A1	gene symbol: SEC61A1. Functionality: protein translocation across er membrane, protein sorting, integral to er-associated degradation. Phenotype: linked to her2-positive breast cancer progression, impacts cellular protein processing and stability. 
CLDN3	gene symbol: CLDN3. Functionality: encodes claudin-3 protein, involved in tight junctions and cell-cell adhesion. Phenotype: overexpression associated with increased invasion and metastasis in her2-positive breast cancer. 
PPDPF	gene symbol: PPDPF. Functionality: involved in cellular signaling pathways and gene expression regulation. Phenotype: associated with her2-positive breast cancer cell proliferation and survival. 
S100A14	gene symbol: S100A14. Functionality: calcium-binding protein involved in cell migration, proliferation, and differentiation. Phenotype: altered expression linked to her2-positive breast cancer progression and metastasis. 
BGN	gene symbol: BGN. Functionality: encodes biglycan, involved in extracellular matrix assembly, collagen binding, and cell signaling. Phenotype: may influence tumor progression, promotes cell proliferation, and modulates immune response in her2-positive breast cancer. 
C3	gene symbol: C3. Functionality: complement system activation, immune response modulation, opsonization, inflammation mediation, pathogen clearance. Phenotype: increased susceptibility to infections, potential autoimmune disorders, altered immune system response, possible impact on cancer progression. 
MZT2B	gene symbol: MZT2B. Functionality: microtubule organization, centrosome function, cell division. Phenotype: her2-positive breast cancer proliferation, metastasis potential. 
S100A8	gene symbol: S100A8. Functionality: calcium-binding protein involved in inflammation, immune response, and cell cycle regulation. Phenotype: associated with tumor progression, metastasis, and immune cell recruitment in her2-positive breast cancer. 
MDK	gene symbol: MDK. Functionality: growth factor, enhances cell proliferation, migration, angiogenesis. Phenotype: her2-positive breast cancer, promotes tumor progression, resistance to therapy. 
PFDN5	gene symbol: PFDN5. Functionality: pfdn5 encodes prefoldin subunit 5, involved in cytoskeletal organization and protein folding, assists in chaperone-mediated folding of actin and tubulin. Phenotype: altered expression may contribute to cancer progression, including her2-positive breast cancer. 
H2AFJ	gene symbol: H2AFJ. Functionality: histone variant involved in chromatin structure modulation. Phenotype: altered expression linked to cancer progression, including her2-positive breast cancer. 
SH3BGRL3	gene symbol: SH3BGRL3. Functionality: signal transduction, interacts with signaling proteins, modulates cellular responses. Phenotype: altered expression in her2-positive breast cancer, impacts cell growth and survival. 
ENO1	gene symbol: ENO1. Functionality: glycolysis enzyme, catalyzes conversion of 2-phosphoglycerate to phosphoenolpyruvate. Phenotype: overexpression linked to tumor progression, metastasis, and poor prognosis in her2-positive breast cancer. 
XBP1	gene symbol: XBP1. Functionality: regulation of the unfolded protein response, transcription factor, cell proliferation, apoptosis. Phenotype: her2-positive breast cancer progression, altered cellular stress response, increased cell survival. 
CYBA	gene symbol: CYBA. Functionality: encodes p22phox component of nadph oxidase complex; involved in reactive oxygen species production. Phenotype: altered expression may affect oxidative stress regulation; implicated in cancer progression. 
COX6B1	gene symbol: COX6B1. Functionality: encodes subunit vib of cytochrome c oxidase complex; involved in electron transport chain. Phenotype: altered mitochondrial function; energy production disruption; potential involvement in tumorigenesis. 
TRAF4	gene symbol: TRAF4. Functionality: adaptor protein in signal transduction, interacts with tnf receptor family, involved in apoptosis, cell proliferation. Phenotype: promotes tumor progression, associated with her2-positive breast cancer, impacts cell cycle regulation, enhances invasive potential. 
CD24	gene symbol: CD24. Functionality: signal transduction, cell adhesion, immune response modulation. Phenotype: her2-positive breast cancer progression, metastasis propensity, tumor cell proliferation. 
PRSS8	gene symbol: PRSS8. Functionality: serine protease involved in epithelial sodium channel regulation and skin barrier maintenance. Phenotype: altered expression may contribute to tumorigenesis and progression in her2-positive breast cancer. 
MMP14	gene symbol: MMP14. Functionality: encodes membrane-bound matrix metalloproteinase involved in extracellular matrix remodeling, cell migration, and invasion. Phenotype: contributes to tumor progression, metastasis, and angiogenesis in her2-positive breast cancer. 
MUC1	gene symbol: MUC1. Functionality: encodes a transmembrane glycoprotein involved in cell signaling, adhesion, and immune response modulation. Phenotype: overexpression in her2-positive breast cancer contributes to tumor progression and immune evasion. 
VIM	gene symbol: VIM. Functionality: encodes vimentin, involved in cytoskeletal structure, cell adhesion, and proliferation. Phenotype: linked to tumor progression, metastasis, and poor prognosis in her2-positive breast cancer. 
MIDN	gene symbol: MIDN. Functionality: involved in mitochondrial distribution and dynamics. Phenotype: linked to altered energy metabolism, potential role in her2-positive breast cancer. 
SPINT2	gene symbol: SPINT2. Functionality: inhibitor of serine proteases, regulates epithelial cell growth and differentiation. Phenotype: associated with her2-positive breast cancer progression, impacts tumor growth and metastasis. 
BST2	gene symbol: BST2. Functionality: involves in immune response, inhibits virus release from cells, regulates cell signaling pathways. Phenotype: altered bst2 expression associates with cancer progression, impacts cell proliferation, influences tumor environment in her2-positive breast cancer. 
TIMP1	gene symbol: TIMP1. Functionality: inhibits matrix metalloproteinases, regulates extracellular matrix, influences cell proliferation. Phenotype: altered expression impacts tumor growth, invasion, angiogenesis in her2-positive breast cancer. 
GUK1	gene symbol: GUK1. Functionality: catalyzes guanylate monophosphate conversion to guanosine diphosphate. Phenotype: may affect cell proliferation and metabolism; potential role in cancer progression. 
ACTN4	gene symbol: ACTN4. Functionality: actn4 encodes alpha-actinin-4, involved in cytoskeletal organization and cell motility. Phenotype: overexpression linked to metastasis, aggressive tumor behaviors, and poor prognosis in her2-positive breast cancer. 
CTSB	gene symbol: CTSB. Functionality: encodes cathepsin b, a lysosomal cysteine protease involved in protein degradation and processing. Phenotype: overexpression linked to tumor growth, metastasis, and poor prognosis in her2-positive breast cancer. 
COX4I1	gene symbol: COX4I1. Functionality: encodes cytochrome c oxidase (cox) subunit iv isoform 1; involved in mitochondrial electron transport chain. Phenotype: linked to cellular energy metabolism; potential role in tumor cell proliferation and survival. 
CCT3	gene symbol: CCT3. Functionality: involved in protein folding, part of the chaperonin-containing tcp-1 complex, assists in folding of cytoskeletal proteins. Phenotype: potentially linked to cancer progression, overexpression may contribute to cell proliferation in her2-positive breast cancer. 
HNRNPA2B1	gene symbol: HNRNPA2B1. Functionality: rna binding, mrna processing, splicing regulation, gene expression modulation. Phenotype: altered cell proliferation, metastasis enhancement, increased tumor growth in her2-positive breast cancer. 
SEPW1	gene symbol: SEPW1. Functionality: encodes selenoprotein w involved in antioxidant defense, regulation of cell cycle, and apoptosis. Phenotype: altered expression linked to tumor progression, cell proliferation, and survival in her2-positive breast cancer. 
LY6E	gene symbol: LY6E. Functionality: involved in immune regulation, interferon response, viral infection defense. Phenotype: expression linked to cancer proliferation, immune evasion, metastatic progression. 
SCD	gene symbol: SCD. Functionality: catalyzes synthesis of monounsaturated fats, impacts lipid metabolism. Phenotype: associated with altered lipid profiles, potential role in cancer cell proliferation. 
HSPB1	gene symbol: HSPB1. Functionality: encodes heat shock protein, involved in stress response, apoptosis regulation, protein folding, and cellular protection. Phenotype: altered expression linked to her2-positive breast cancer, influencing cell survival, proliferation, and metastasis. 
EIF4G2	gene symbol: EIF4G2. Functionality: regulates translation initiation; interacts with eif4a, eif4e, and poly(a)-binding protein; modulates mrna stability. Phenotype: associated with altered cell proliferation; implicated in her2-positive breast cancer progression. 
BSG	gene symbol: BSG. Functionality: encodes basigin protein involved in cell adhesion, recognition, and signaling. Phenotype: overexpression linked to tumor growth, angiogenesis, and metastasis in her2-positive breast cancer. 
ZYX	gene symbol: ZYX. Functionality: zyx encodes a cytoskeletal protein involved in cell adhesion and signal transduction. Phenotype: altered expression impacts cell motility and proliferation, potentially influencing cancer progression. 
TUBB	gene symbol: TUBB. Functionality: encodes beta-tubulin, microtubule formation, intracellular transport, mitosis. Phenotype: cell proliferation, tumorigenesis, her2-positive breast cancer progression. 
LASP1	gene symbol: LASP1. Functionality: scaffold protein involved in cytoskeletal organization and cell migration. Phenotype: overexpression linked to her2-positive breast cancer, promoting tumor progression and metastasis. 
CD99	gene symbol: CD99. Functionality: cell adhesion; apoptosis; immune response modulation. Phenotype: influences tumor progression; associated with metastasis; affects immune cell activity. 
COL6A2	gene symbol: COL6A2. Functionality: encodes component of extracellular matrix; involved in cell adhesion, tissue integrity. Phenotype: may contribute to tumor progression; associated with her2-positive breast cancer. 
H1FX	gene symbol: H1FX. Functionality: regulates chromatin structure, involved in gene expression modulation, contributes to cell cycle progression. Phenotype: altered cell growth, potential role in cancer development, impacts cellular response to dna damage. 
RALY	gene symbol: RALY. Functionality: rna binding, regulation of transcription and translation, involvement in splicing. Phenotype: altered expression observed in cancer, potential role in tumorigenesis, linked to her2-positive breast cancer. 
UBE2M	gene symbol: UBE2M. Functionality: encodes a ubiquitin-conjugating enzyme involved in protein degradation via neddylation. Phenotype: altered protein levels can impact cell cycle, potentially influencing cancer progression. 
SPARC	gene symbol: SPARC. Functionality: involved in cell-matrix interactions, regulates cell growth and adhesion. Phenotype: altered expression linked to tumor progression in her2-positive breast cancer. 
ATG10	gene symbol: ATG10. Functionality: autophagy-related protein involved in autophagosome formation. catalyzes lipidation of atg12-atg5 conjugate. plays role in cellular homeostasis. Phenotype: altered autophagy may affect cancer cell survival. potential role in oncogenesis. implicated in cellular stress responses. 
HSP90AB1	gene symbol: HSP90AB1. Functionality: molecular chaperone, protein folding, stabilization, signal transduction, cell cycle control. Phenotype: enhanced tumor growth, resistance to therapy, aggressive cancer progression, her2-positive breast cancer association. 
ORMDL3	gene symbol: ORMDL3. Functionality: regulates sphingolipid synthesis, involved in endoplasmic reticulum stress response. Phenotype: associated with asthma, inflammatory bowel disease; potential role in her2-positive breast cancer. 
LMAN2	gene symbol: LMAN2. Functionality: involved in glycoprotein transport and quality control in the endoplasmic reticulum. Phenotype: may contribute to alterations in glycoprotein processing affecting cell signaling pathways linked to her2-positive breast cancer. 
CHCHD2	gene symbol: CHCHD2. Functionality: involved in mitochondrial function and oxidative phosphorylation. Phenotype: altered expression linked to various cancers, including potential involvement in her2-positive breast cancer. 
COX7C	gene symbol: COX7C. Functionality: encodes a cytochrome c oxidase subunit involved in electron transport chain and mitochondrial respiration. Phenotype: altered expression may impact cellular energy metabolism and contribute to tumorigenesis in her2-positive breast cancer. 
ARHGDIA	gene symbol: ARHGDIA. Functionality: regulates rho gtpases, controls cell morphology, motility, proliferation. Phenotype: altered expression linked to cancer progression, including metastasis in her2-positive breast cancer. 
VMP1	gene symbol: VMP1. Functionality: autophagy regulation, cell membrane formation, apoptosis facilitation. Phenotype: altered cellular homeostasis, increased susceptibility to stress, potential tumor progression. 
UBC	gene symbol: UBC. Functionality: encodes ubiquitin involved in protein degradation, cell cycle, signal transduction. Phenotype: altered expression linked to cancer progression, affects cell proliferation, metastasis. 
IGFBP2	gene symbol: IGFBP2. Functionality: regulates insulin-like growth factors, modulates cell growth, apoptosis, and metabolism. Phenotype: involvement in cancer progression, metastasis, and poor prognosis in her2-positive breast cancer. 
COPE	gene symbol: COPE. Functionality: involved in vesicle transport and fusion, part of coatomer complex. Phenotype: potential alteration in cellular transport processes, impact on growth signaling pathways. 
NUPR1	gene symbol: NUPR1. Functionality: transcription cofactor, regulates cellular stress response, modulates apoptosis and proliferation. Phenotype: altered expression linked to tumorigenesis, influences cancer cell survival and metastasis. 
PERP	gene symbol: PERP. Functionality: encodes p53 apoptosis effector, involved in cell-cell adhesion and apoptosis. Phenotype: associated with her2-positive breast cancer progression, influences tumor cell survival and metastasis. 
KRT81	gene symbol: KRT81. Functionality: involved in hair follicle development and keratinocyte differentiation. Phenotype: hair structure abnormalities, potential link to her2-positive breast cancer aggressiveness. 
PPP1R1B	gene symbol: PPP1R1B. Functionality: regulates protein phosphatase 1 activity, involved in dopamine signaling. Phenotype: altered expression linked to neuropsychiatric disorders, potential role in her2-positive breast cancer. 
LGALS3BP	gene symbol: LGALS3BP. Functionality: involved in cell-cell adhesion, immune response modulation, and extracellular matrix interaction. Phenotype: associates with tumor progression, metastasis, and resistance in her2-positive breast cancer. 
SSR2	gene symbol: SSR2. Functionality: involved in protein translocation into the endoplasmic reticulum; part of the signal sequence receptor complex. Phenotype: associates with altered protein processing; potential implications in cancer biology, including her2-positive breast cancer. 
KIAA0100	gene symbol: KIAA0100. Functionality: involved in signal transduction, may interact with her2 pathway, influences cell proliferation. Phenotype: altered expression associated with tumor growth, progression in her2-positive breast cancer. 
MYL9	gene symbol: MYL9. Functionality: regulates actin-myosin interaction, modulates cellular contraction. Phenotype: influences cell motility, could affect tumor progression. 
CIB1	gene symbol: CIB1. Functionality: calcium-binding protein; modulates cell signaling, apoptosis, angiogenesis. Phenotype: her2-positive breast cancer; influences proliferation, survival, metastatic potential. 
IDH2	gene symbol: IDH2. Functionality: catalyzes oxidative decarboxylation of isocitrate to alpha-ketoglutarate; involved in cellular metabolism. Phenotype: mutations associated with cancer, including her2-positive breast cancer; impacts cellular proliferation. 
STARD10	gene symbol: STARD10. Functionality: lipid transfer; phospholipid transport; signal transduction. Phenotype: altered lipid metabolism; tumor progression; therapeutic target in her2-positive breast cancer. 
LGALS1	gene symbol: LGALS1. Functionality: encodes galectin-1, involved in cell-cell adhesion, immune response, apoptosis regulation. Phenotype: promotes tumorigenesis in her2-positive breast cancer, affects cancer cell proliferation and metastasis. 
COX6C	gene symbol: COX6C. Functionality: encodes cytochrome c oxidase subunit, involved in mitochondrial electron transport chain. Phenotype: altered expression may affect oxidative phosphorylation, impacting energy metabolism in her2-positive breast cancer cells. 
GRN	gene symbol: GRN. Functionality: encodes progranulin, involved in cell growth, survival, and inflammation modulation. Phenotype: alterations linked to neurodegenerative diseases; potential cancer progression role. 
MAPKAPK2	gene symbol: MAPKAPK2. Functionality: signal transduction, inflammation response, cell stress regulation. Phenotype: altered cell proliferation, increased tumorigenesis, her2-positive breast cancer progression. 
GNAI2	gene symbol: GNAI2. Functionality: gnai2 encodes g protein subunit alpha i2, involved in signal transduction, inhibiting adenylate cyclase, regulating various signaling pathways. Phenotype: altered gnai2 expression linked to tumor progression, her2-positive breast cancer cell proliferation, affecting response to therapy. 
KDELR1	gene symbol: KDELR1. Functionality: encodes a kdel receptor in the golgi, mediating retrograde transport of er proteins. Phenotype: altered kdelr1 expression may affect protein trafficking, potentially influencing her2-positive breast cancer progression. 
COL18A1	gene symbol: COL18A1. Functionality: encodes endostatin; inhibits angiogenesis; interacts with extracellular matrix; impacts cell adhesion. Phenotype: altered expression linked to tumor growth; influences metastasis; associated with her2-positive breast cancer progression. 
UQCRQ	gene symbol: UQCRQ. Functionality: encodes a subunit of the cytochrome bc1 complex, involved in electron transport chain and atp production. Phenotype: alterations may impact mitochondrial function; potential role in cellular energy metabolism in breast cancer. 
COX5B	gene symbol: COX5B. Functionality: encodes subunit of cytochrome c oxidase; involved in mitochondrial electron transport. Phenotype: altered expression may contribute to cancer progression; potential role in tumor metabolism. 
ELOVL1	gene symbol: ELOVL1. Functionality: involved in fatty acid elongation, synthesizes long-chain saturated and monounsaturated fatty acids. Phenotype: altered lipid metabolism, potential role in cancer progression. 
CHPF	gene symbol: CHPF. Functionality: involved in chondroitin sulfate biosynthesis, polymerization of glycosaminoglycans. Phenotype: associated with her2-positive breast cancer, affects tumor growth, cell proliferation. 
CLDN4	gene symbol: CLDN4. Functionality: encodes transmembrane protein part of tight junctions regulating paracellular transport and barrier function in epithelial cells. Phenotype: altered expression linked to tumorigenesis and metastasis in her2-positive breast cancer. 
C12orf57	gene symbol: C12orf57. Functionality: involved in cellular processes; interacts with proteins affecting cell proliferation. Phenotype: linked to developmental disorders; potential modifier in her2-positive breast cancer. 
LGALS3	gene symbol: LGALS3. Functionality: encodes galectin-3, involved in cell-cell adhesion, immune response regulation, and apoptosis. Phenotype: overexpression linked to tumor progression, metastasis, and poor prognosis in her2-positive breast cancer. 
HSP90AA1	gene symbol: HSP90AA1. Functionality: encodes heat shock protein 90 alpha, chaperone stabilizing proteins, supporting maturation and degradation. Phenotype: her2-positive breast cancer progression, resistance to targeted therapies, affects cell survival and proliferation. 
JUP	gene symbol: JUP. Functionality: encodes junction plakoglobin, component of desmosomes and adherens junctions, involved in cell adhesion and signaling. Phenotype: associated with altered cell adhesion, impacts tumor progression, linked to her2-positive breast cancer aggressiveness. 
A2M	gene symbol: A2M. Functionality: protease inhibitor, cytokine carrier, immune response modulation, inflammation reduction. Phenotype: her2-positive breast cancer association, altered immune response, protease regulation, tumor progression. 
NDUFB7	gene symbol: NDUFB7. Functionality: part of mitochondrial complex i, involved in electron transport chain. Phenotype: altered expression may affect cellular energy metabolism, potentially impacting cancer cell proliferation. 
PGAP3	gene symbol: PGAP3. Functionality: encodes enzyme involved in gpi-anchor protein maturation; facilitates lipid remodeling. Phenotype: altered lipid composition affects cell surface protein expression; linked to her2-positive breast cancer progression. 
HSPA8	gene symbol: HSPA8. Functionality: involved in protein folding, transport, and degradation; regulates heat shock response. Phenotype: cellular survival under stress, impacts cancer progression; associated with her2-positive breast cancer. 
TCEB2	gene symbol: TCEB2. Functionality: component of transcription elongation factor b complex, regulates rna polymerase ii, involved in transcription elongation. Phenotype: altered expression may impact cancer progression, associated with tumor growth in her2-positive breast cancer. 
PEBP1	gene symbol: PEBP1. Functionality: regulates cell signaling, inhibits raf kinase, modulates apoptosis. Phenotype: altered expression linked to tumor progression, metastasis, resistance in her2-positive breast cancer. 
COPS9	gene symbol: COPS9. Functionality: regulates ubiquitin-mediated protein degradation, part of cop9 signalosome complex. Phenotype: potential involvement in tumor progression, signaling pathways, and protein homeostasis in her2-positive breast cancer. 
ATP5G2	gene symbol: ATP5G2. Functionality: encodes mitochondrial atp synthase subunit c involved in atp synthesis. Phenotype: altered expression linked to cancer metabolism and potential impact on tumor growth. 
ATP6AP1	gene symbol: ATP6AP1. Functionality: associated with vacuolar proton-transporting atpase complex, involved in acidification of intracellular organelles. Phenotype: potential role in cell proliferation, contributing to tumor progression in her2-positive breast cancer. 
MYH9	gene symbol: MYH9. Functionality: encodes myosin iia heavy chain, involved in cell motility, maintenance of cell shape, and cytokinesis. Phenotype: mutations linked to macrothrombocytopenia, sensorineural hearing loss, and nephropathy; potential involvement in her2-positive breast cancer progression. 
LSM4	gene symbol: LSM4. Functionality: component of the lsm protein complex involved in mrna splicing and degradation. Phenotype: altered expression linked to tumorigenesis and cancer progression. 
COX8A	gene symbol: COX8A. Functionality: encodes subunit of cytochrome c oxidase, involved in electron transport chain and atp production. Phenotype: altered expression linked to cancer metabolism including her2-positive breast cancer. 
UQCR11	gene symbol: UQCR11. Functionality: component of mitochondrial complex iii, involved in electron transport chain, energy production. Phenotype: altered expression linked to cancer metabolism and progression in her2-positive breast cancer. 
ATP5B	gene symbol: ATP5B. Functionality: encodes beta subunit of atp synthase; involved in atp production via oxidative phosphorylation. Phenotype: altered energy metabolism; potential link to tumor growth in her2-positive breast cancer. 
DHCR24	gene symbol: DHCR24. Functionality: involved in cholesterol biosynthesis; catalyzes reduction of desmosterol to cholesterol. Phenotype: altered cholesterol levels; potential role in cancer cell proliferation and survival. 
PTBP1	gene symbol: PTBP1. Functionality: regulates alternative splicing and mrna stability, involved in rna processing. Phenotype: altered expression linked to cancer progression, affects tumor growth and metastasis. 
EIF3B	gene symbol: EIF3B. Functionality: part of eif3 complex, regulates translation initiation. Phenotype: overexpression linked to her2-positive breast cancer progression. 
NDUFA3	gene symbol: NDUFA3. Functionality: encodes mitochondrial complex i subunit, involved in electron transport chain. Phenotype: altered mitochondrial function, potential impact on cellular energy production. 
FKBP2	gene symbol: FKBP2. Functionality: protein folding, immunoregulation, chaperone activity. Phenotype: altered immune response, potential role in cancer cell proliferation. 
MMACHC	gene symbol: MMACHC. Functionality: involved in vitamin b12 metabolism; converts cyanocobalamin and hydroxocobalamin into active forms. Phenotype: deficiency can lead to methylmalonic acidemia and homocystinuria; related to neurological issues and developmental delays. 
RABAC1	gene symbol: RABAC1. Functionality: rabac1 is involved in vesicle trafficking and membrane fusion processes, potentially affecting intracellular transport pathways. Phenotype: alterations in rabac1 may influence cellular growth patterns and signaling pathways, contributing to tumorigenic processes in her2-positive breast cancer. 
ISG15	gene symbol: ISG15. Functionality: involved in immune response; ubiquitin-like protein modification; antiviral defense. Phenotype: altered expression may affect tumor progression; potential role in her2-positive breast cancer. 
PTMA	gene symbol: PTMA. Functionality: encodes prothymosin alpha, involved in cell proliferation and apoptosis regulation. Phenotype: altered expression associated with her2-positive breast cancer progression and therapeutic response. 
RRBP1	gene symbol: RRBP1. Functionality: encodes ribosome-binding protein, involved in er protein translocation and ribosome interaction. Phenotype: associated with her2-positive breast cancer, influences cell proliferation and metastasis. 
POSTN	gene symbol: POSTN. Functionality: encodes periostin; involved in extracellular matrix organization; promotes cell adhesion, migration, and proliferation. Phenotype: contributes to tumor growth; associated with poor prognosis in her2-positive breast cancer; involved in metastasis. 
C1QB	gene symbol: C1QB. Functionality: part of c1 complex in complement system, immune response, opsonization. Phenotype: her2-positive breast cancer progression, immune modulation, tumor microenvironment alteration. 
BCAP31	gene symbol: BCAP31. Functionality: involved in er-to-golgi transport, interacts with bcl2 proteins, regulates apoptosis. Phenotype: may influence breast cancer progression, associated with her2-positive cancer cell survival. 
PSMB4	gene symbol: PSMB4. Functionality: encodes a subunit of the proteasome involved in protein degradation and processing. Phenotype: altered expression linked to cell cycle regulation, apoptosis, and tumor progression in her2-positive breast cancer. 
LAPTM4A	gene symbol: LAPTM4A. Functionality: membrane protein involved in lysosomal transport, regulation of intracellular ph, and protein sorting. Phenotype: altered expression linked to cellular proliferation, potentially impacting her2-positive breast cancer progression. 
INTS1	gene symbol: INTS1. Functionality: part of integrator complex, regulates transcription, rna processing. Phenotype: altered expression in her2-positive breast cancer, impacts cell proliferation, survival. 
FNBP1L	gene symbol: FNBP1L. Functionality: involved in cell signaling, cytoskeletal organization, and membrane trafficking. Phenotype: linked to cell proliferation and tumor progression in her2-positive breast cancer. 
JTB	gene symbol: JTB. Functionality: involved in cell proliferation, apoptosis regulation, and signal transduction. Phenotype: potentially contributes to tumorigenesis in her2-positive breast cancer, affecting cell growth and survival. 
NBL1	gene symbol: NBL1. Functionality: encodes a protein that regulates cell growth and differentiation. Phenotype: associated with tumor progression in her2-positive breast cancer. 
HM13	gene symbol: HM13. Functionality: hm13 encodes signal peptide peptidase, involved in intramembrane proteolysis and protein processing. Phenotype: altered hm13 expression may influence cancer progression; its relation to her2-positive breast cancer is under investigation. 
SLC2A4RG	gene symbol: SLC2A4RG. Functionality: transcriptional regulator; interacts with glut4 promoter; involved in glucose transport regulation. Phenotype: influences glucose metabolism; potential role in insulin response; unclear specific phenotype in her2-positive breast cancer. 
ROMO1	gene symbol: ROMO1. Functionality: involved in reactive oxygen species production, mitochondrial homeostasis, regulation of cell proliferation. Phenotype: altered mitochondrial function, increased oxidative stress, enhanced cancer cell growth. 
SERINC2	gene symbol: SERINC2. Functionality: incorporates serine into phospholipids, involved in cell membrane synthesis. Phenotype: altered expression related to cellular proliferation, impacts cancer progression. 
NDUFA11	gene symbol: NDUFA11. Functionality: encodes a subunit of mitochondrial complex i involved in respiratory electron transport and atp production. Phenotype: altered expression may impact cellular energy metabolism and contribute to tumorigenesis in her2-positive breast cancer. 
RHOC	gene symbol: RHOC. Functionality: gtpase activity; regulates cytoskeletal dynamics; cell migration; cell proliferation. Phenotype: increased cell invasion; enhanced metastatic potential; associated with tumor progression in her2-positive breast cancer. 
TXNIP	gene symbol: TXNIP. Functionality: regulates oxidative stress, influences glucose metabolism, inhibits thioredoxin activity. Phenotype: potentially contributes to tumor progression, associated with metabolic disorders and cancer. 
TYMP	gene symbol: TYMP. Functionality: encodes enzyme thymidine phosphorylase involved in thymidine metabolism and angiogenesis. Phenotype: overexpression linked with tumor growth, metastasis, and poor prognosis in her2-positive breast cancer. 
NACA	gene symbol: NACA. Functionality: involved in regulation of apoptosis, stress response, and modulation of signaling pathways. Phenotype: associated with tumor progression and metastasis in her2-positive breast cancer. 
HSP90B1	gene symbol: HSP90B1. Functionality: encodes heat shock protein 90 beta member 1; assists protein folding, stability, and degradation. Phenotype: overexpression linked to her2-positive breast cancer; contributes to cancer cell proliferation and survival. 
SNRPB	gene symbol: SNRPB. Functionality: component of spliceosomal snrnps, involved in mrna splicing. Phenotype: altered expression may contribute to cancer progression and metastasis. 
PFKL	gene symbol: PFKL. Functionality: catalyzes conversion of fructose-6-phosphate to fructose-1,6-bisphosphate in glycolysis. Phenotype: altered pfkl expression may affect glucose metabolism and contribute to tumor progression in her2-positive breast cancer. 
VCP	gene symbol: VCP. Functionality: protein degradation, dna repair, cell cycle regulation. Phenotype: cancer progression, metastasis, apoptosis resistance. 
ERGIC1	gene symbol: ERGIC1. Functionality: involved in membrane trafficking, er-golgi intermediate compartment, transport of proteins. Phenotype: potential alterations in cellular transport, implications in cancer progression, association with her2-positive breast cancer. 
NUCKS1	gene symbol: NUCKS1. Functionality: chromatin organization, dna repair, transcriptional regulation. Phenotype: altered cell proliferation, implicated in cancer progression. 
PSMD8	gene symbol: PSMD8. Functionality: part of the 26s proteasome; involved in protein degradation and regulation of ubiquitin pathway. Phenotype: associated with altered cell cycle control and proliferation; impacts tumor progression in her2-positive breast cancer. 
CALM2	gene symbol: CALM2. Functionality: encodes calmodulin protein, regulates calcium signaling, influences cell cycle, apoptosis, and gene expression. Phenotype: altered expression linked to her2-positive breast cancer; affects tumor progression, metastasis, and therapeutic resistance. 
AP2S1	gene symbol: AP2S1. Functionality: involved in endocytosis, clathrin-mediated vesicle formation, regulates receptor internalization. Phenotype: may influence cancer cell growth, metastasis, therapeutic resistance in her2-positive breast cancer. 
DBI	gene symbol: DBI. Functionality: involved in lipid metabolism, benzodiazepine receptor binding, and modulation of gabaergic transmission. Phenotype: potential impact on cancer cell growth and proliferation, associated with her2-positive breast cancer progression. 
C4orf48	gene symbol: C4orf48. Functionality: potential involvement in cellular processes; exact biological function not well-defined. Phenotype: association with her2-positive breast cancer; phenotype implications unclear. 
SDF4	gene symbol: SDF4. Functionality: protein folding, glycosylation, calcium binding. Phenotype: her2-positive breast cancer proliferation, metastasis, survival. 
TPI1	gene symbol: TPI1. Functionality: encodes triosephosphate isomerase involved in glycolysis, catalyzing isomerization of glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. Phenotype: mutations linked to triosephosphate isomerase deficiency, resulting in neurological dysfunction and hemolytic anemia. 
